Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer’s Disease and Related Disorders

, , , &
American Journal of Bioethics Neuroscience 14 (2):129-131 (2023)
  Copy   BIBTEX

Abstract

Peterson et al. (2023) identify two potential uses of psychedelic drugs in Alzheimer’s disease and related disorders (AD/ADRD). The first is to treat depression and anxiety that commonly occur afte...

Categories

Keywords

Reprint years

DOI

10.1080/21507740.2023.2188287

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,423

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Publishing the Biotechnical Futures of Alzheimer’s Disease.James Rupert Fletcher - 2023 - American Journal of Bioethics Neuroscience 14 (2):124-126.
Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias.Andrew Peterson, Emily A. Largent, Holly Fernandez Lynch, Jason Karlawish & Dominic Sisti - 2023 - American Journal of Bioethics Neuroscience 14 (2):107-123.
Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care.Hojjat Soofi & Cynthia Forlini - 2023 - American Journal of Bioethics Neuroscience 14 (2):131-134.
Cognitive Aging: What We Fear and What We Know.I. I. Dan G. Blazer - 2018 - Perspectives in Biology and Medicine 60 (4):569-582.
Alzheimer's Disease and Related Disorders. Etiology, Pathogenesis, and Therapeutics.H. T. Wright - 2000 - Bioessays 22 (7):682-683.
To Know or Not to Know - Ethical Issues Related to Early Diagnosis of Alzheimer's Disease.Niklas Mattsson, David Brax & Henrik Zetterberg - 2010 - International Journal of Alzheimer's Disease.
Descartes RV 5-8. 14. 25 diagnosis of Alzheimer's disease 132 Down syndrome 67. 132 early detection of brain pathology in Alzheimer's disease 131-143. [REVIEW]C. Bernard - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 80--151.
Research involving subjects with Alzheimer’s disease in Italy: the possible role of family members.Corinna Porteri & Carlo Petrini - 2015 - BMC Medical Ethics 16 (1):12.
The NGF superfamily of neurotrophins: Potential treatment for Alzheimer's and Parkinson's disease.Elliott J. Mufson & Teresa Sobreviela - 1995 - Behavioral and Brain Sciences 18 (1):63-65.
The right not to know: the case of psychiatric disorders.Lisa Bortolotti & Heather Widdows - 2011 - Journal of Medical Ethics 37 (11):673-676.
Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer’s Disease and Related Dementias.Kaila A. Rudolph - 2023 - American Journal of Bioethics Neuroscience 14 (2):136-138.
Clinical and neuropsychological correlates of impaired awareness of deficits in alzheimer disease and Parkinson disease: A comparative study.Benjamin Seltzer, Jennifer J. Vasterling, Charles W. Mathias & Angela Brennan - 2001 - Neuropsychiatry, Neuropsychology, and Behavioral Neurology 14 (2):122-129.
Ageing population in the developed countries: some ethical consequences.C. Susanne - 1999 - Global Bioethics 12 (1-4):89-98.
A Cognitive Neuroscience of Alzheimer's Disease: What Can Be Learned from Studies of visual Imagery?S. M. Kosslyn & I. E. Dror - 1992 - In Y. Christen & P. S. Churchland (eds.), Neurophilosophy and Alzheimer's Disease. Springer Verlag. pp. 49--59.
Ageing population in the developed countries: some ethical consequences.M. Szente & C. Susanne - 1999 - Global Bioethics 12 (1-4):89-98.

Analytics

Added to PP
2023-04-27

Downloads
14 (#968,362)

6 months
9 (#295,075)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

John Gardner
James Madison University

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references